Curi Bio

That’s a wrap, Seoul! ✨ Huge thanks to everyone who packed the room for @Curi_Bio's session and visited us at BIO KOREA 2026. We’re inspired by the support from our partners and the future of drug discovery in Korea! 🤝 Contact us: hubs.ly/Q04fbq2h0 #BioKorea2026 #NAMs

Happy #FluorescenceFriday! 🔬🧠 Spontaneous calcium transients in @28bio CNS-3D Brain Organoids captured on @Curi_Bio Nautilai™. Dose-dependent, mechanism-consistent pharmacology in a 384-well format. 🔗Read here hubs.ly/Q04f4CCd0 #BrainOrganoids #CalciumImaging #3DBiology

May is #ALSAwarenessMonth. For patients and families, every day is a race against time. ⏱️ At @Curi_Bio, we’re moving beyond animal proxies to study disease in human-relevant 3D tissues. We stand with the #ALS community to redefine the human standard for drug discovery. #EndALS

Something pivotal is coming to Washington DC. Scalability in drug discovery ends this May at #MPS2026. We’re moving beyond standalone tools to unveil a truly integrated ecosystem of Cells, Systems, & Data. Visit Curi Bio at Booth 121! hubs.ly/Q04dSk8r0 #DrugDiscovery #NAMs

"HAPPENING TODAY at #BioKorea2026! 🚀 Don't miss @Curi_Bio's talk in Room 317 at 10:15 AM. 🎙️ Learn why MOA specificity is the key to bridging the gap between NAMs and clinical reality. 🧬 📍 Visit us at Booth C11 🤝 Book a meeting: hubs.ly/Q04b-wk_0 #NAMs #Biotech

"We’re on the ground at #BioKorea2026! ✨ Visit the @Curi_Bio team at Booth C11 to see how we’re accelerating NAMs adoption with 3D human engineered tissue platforms. 🎙️ Don't miss our talk: 📅 Apr 30 | Room 317 | 10:15AM Book now: hubs.ly/Q04b-_y-0 #NAMs #CuriBio #Biotech

📣On May 26, @Curi_Bio's CEO Dr. Geisse joins @Xtalks to unpack what new FDA draft guidance means for NAMs, 3D models, and drug development pipelines. What’s your biggest barrier to moving from 2D to 3D human-relevant NAMs? 👉hubs.ly/Q04dcwkl0 #NAMs #DrugDiscovery #Pharma

Going to the Cardiovascular Olympiad in Kalamata? 🏛️ Join @Curi_Bio 05/02, 1:30 PM to see how our 3D heart tissues model HCM w/ ✅Hypercontractility & Ca2+ hypersensitivity, ✅Active profibrotic remodeling, ✅Clinical drug response validation Book here! hubs.ly/Q04bc3-K0

Final call for Helsinki! ❄️ The @Curi_Bio team arrive in Finland on April 24th and have a few openings left for 1:1 visits. Don't miss out—secure a final slot here:hubs.ly/Q04cyT4v0🔗 #CuriBio #DrugDiscovery #3DBiology #Finland

Heading to #BioKorea2026? 🌆 Stop by Booth C11 to meet the @Curi_Bio Korea team! Learn how our 3D engineered human tissues & MOA specification are bridging the gap to clinical reality.🎙️Don't miss our talk Apr 30, Room 317! Book a meeting: hubs.ly/Q04b-Wc80 #NAMs #Biotech

Final call for Germany! 🥨 The @Curi_Bio team arrives in South Germany & Berlin on Monday! ✈️ We have a few slots left for an in-person visit or demo. See our 3D muscle models in action! 🔗 Book now: hubs.ly/Q04b1t6f0 #GermanyScience #NAMs #Biotech #Berlin

The scalability bottleneck ends here. 🛑 Join @Curi_Bio CEO Nicholas Geisse for an @Xtalks webinar 5/26 to unveil a new roadmap for regulatory-grade NAMs. Learn how to scale 3D human functional models for IND. 🧪 👉: hubs.ly/Q04cgmhf0 #Pharma #NAMs #DrugDevelopment

Curi Bio is heading to Helsinki! 🎿 The @Curi_Bio team will be in Finland from April 24–27 for client demos and consultations. We believe groundbreaking research deserves a personalized touch. Book your visit: hubs.ly/Q04b245m0 #CuriBio #DrugDiscovery #3DBiology #Finland

📣 Exciting news! @Curi_Bio is presenting at #BioKorea2026 on accelerating NAMs adoption through MOA specification & functional correlation. 📍Apr 30 | 10:15 AM | Room 317. Bridge the gap between in vitro data & clinical reality. Book a 1:1: hubs.ly/Q04bT0Fn0 #BioKorea2026

Curi Bio is heading to Germany! 🍺 Meet the @Curi_Bio team in South Germany & Berlin (April 20-24) for instrument installs, demos, and 1:1 consultations. Space is limited, book you visit now! 🔗 Connect here: hubs.ly/Q04b19Fw0 #CuriBio #NAMs #Biotech #DrugDevelopment

📣 Final call: Join @CuriBio on April 15 to see why the Mouse Lethality Bioassay's days are numbered. ✅ Optogenetically-driven innervation ✅ 10x more reproducible than MLB ✅ Neuromuscular disease modeling Register 👉 hubs.ly/Q049YcWt0 #NAMs #ALS #SMA #BoNT

Final call for Denmark & Sweden – only a few slots remain! The @Curi_Bio team is on the ground his week. DM them now to secure a 1:1 consultation on our 3D discovery ecosystem before they depart on April 9th! hubs.ly/Q049XndJ0 #CuriBio #DrugDiscovery #iPSC

The Mouse Lethality Bioassay (MLB) needs a human-relevant upgrade. Join @CuriBio's webinar 04/15 on scalable 3D NMJ models, the future of BoNT potency testing.🚀10x more reproducible than MLB ⚡️ Optogenetic control 📊 Scalable readouts 🤝 A #NAMs priority hubs.ly/Q0495rkQ0

🚀 ICYMI: @NovoNordisk & @CuriBio's landmark #webinar is now ON-DEMAND! 🧬💪See how 3D human muscle is closing the metabolic translational gap with: ✅ Adult-like stability by Day 21 ✅ Reversible exercise gains ✅ Insulin & GLUT4 breakthroughs 🔗 Link: hubs.ly/Q0492Sqq0

Curi Bio is heading to Denmark & Sweden! 🚲 Our @Curi_Bio team is available April 7-9 for 1:1 consultations on our 3D discovery ecosystem. 🧪 Based in Denmark or Sweden? Connect & see how we’re accelerating the path to the clinic! hubs.ly/Q048xPR00 #DrugDiscovery